Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Cancers|October 13, 2021
Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical ImpactCarlos Artigas, Romain Diamand, Qaid Ahmed Shagera, et al.
Current Oncology (Toronto, Ont.)|July 26, 2024
MRI-Targeted Prostate Fusion Biopsy: What Are We Missing outside the Target? Implications for Treatment PlanningMarco Oderda, Alessandro Dematteis, Giorgio Calleris, et al.
BJU International|August 6, 2021
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimensRazvan-George Rahota, Romain Diamand, Bernard Malavaud, et al.
Minerva Urology and Nephrology|July 26, 2021
Contemporary management of benign uretero-enteric strictures after cystectomy: a systematic reviewSimone Albisinni, Fouad Aoun, Georges Mjaess, et al.
World Journal of Urology|April 22, 2024
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation studyRomain Diamand, Jean-Baptiste Roche, Vito Lacetera, et al.
BJU International|March 11, 2026
Targeted microwave ablation of localised prostate cancer (VIOLETTE trial): a prospective multicentre studyNicolas Barry Delongchamps, Alexandre Peltier, Eric Potiron, et al.
World Journal of Urology|September 9, 2024
Active surveillance for low-risk prostate cancer with high tumor burden at biopsy: lessons learned from a contemporary radical prostatectomy cohortJauffray Oliva, Vassili Anastay, Michael Baboudjian, et al.
European Urology Open Science|January 5, 2023
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European StudyOlivier Windisch, Daniel Benamran, Charles Dariane, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2023
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patientsMichael Baboudjian, Alessandro Uleri, Jean-Baptiste Beauval, et al.
World Journal of Urology|January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
Pageof 8